Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 23, 2015, 74 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $987.00 to $64,149,572.70.

Highlighted Stocks Traded by Insiders:

RSP Permian (RSPP) - FREE Research Report

Actoil, Llc, who is 10% Owner at RSP Permian, sold 2.5 million shares at $25.65 on March 23, 2015. Following this transaction, the 10% Owner owned 8.3 million shares meaning that the stake was reduced by 23.12% with the 2.5 million-share transaction.

The shares most recently traded at $25.51, down $0.14, or 0.55% since the insider transaction. Historical insider transactions for RSP Permian go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 45,100
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 87,100
  • 24-Week # shares bought: 22,500
  • 24-Week # shares sold: 129,100

The average volume for RSP Permian has been 1.1 million shares per day over the past 30 days. RSP Permian has a market cap of $2.0 billion and is part of the basic materials sector and energy industry. Shares are up 0.68% year-to-date as of the close of trading on Monday.

RSP Permian, Inc., an independent oil and natural gas company, focuses on the acquisition, exploration, development, and production of unconventional oil and associated liquids-rich natural gas reserves in the Permian Basin of West Texas. The company has a P/E ratio of 859.7. Currently, there are 7 analysts who rate RSP Permian a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RSPP - FREE

TheStreet Quant Ratings rates RSP Permian as a sell. The area that we feel has been the company's primary weakness has been its generally disappointing historical performance in the stock itself. Get the full RSP Permian Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

US Physical Therapy (USPH) - FREE Research Report

Mcafee Lawrance W, who is Chief Financial Officer at US Physical Therapy, sold 2,350 shares at $48.25 on March 23, 2015. Following this transaction, the Chief Financial Officer owned 50,852 shares meaning that the stake was reduced by 4.42% with the 2,350-share transaction.

The shares most recently traded at $48.66, up $0.41, or 0.84% since the insider transaction. Historical insider transactions for US Physical Therapy go as follows:

  • 4-Week # shares bought: 250
  • 4-Week # shares sold: 47,199
  • 12-Week # shares bought: 250
  • 12-Week # shares sold: 47,199
  • 24-Week # shares bought: 250
  • 24-Week # shares sold: 101,072

The average volume for US Physical Therapy has been 58,600 shares per day over the past 30 days. US Physical Therapy has a market cap of $601.2 million and is part of the health care sector and health services industry. Shares are up 16.75% year-to-date as of the close of trading on Monday.

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics in the United States. The stock currently has a dividend yield of 1.24%. The company has a P/E ratio of 28.4. Currently, there are 2 analysts who rate US Physical Therapy a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on USPH - FREE

TheStreet Quant Ratings rates US Physical Therapy as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full US Physical Therapy Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Violin Memory (VMEM) - FREE Research Report

Kurtz William, who is Director at Violin Memory, bought 14,925 shares at $3.35 on March 23, 2015. Following this transaction, the Director owned 14,925 shares meaning that the stake was boosted by 100% with the 14,925-share transaction.

The shares most recently traded at $3.64, up $0.29, or 7.84% since the insider transaction. Historical insider transactions for Violin Memory go as follows:

  • 4-Week # shares bought: 155,000
  • 12-Week # shares bought: 155,000
  • 24-Week # shares bought: 155,000

The average volume for Violin Memory has been 788,000 shares per day over the past 30 days. Violin Memory has a market cap of $329.4 million and is part of the technology sector and computer hardware industry. Shares are down 24.43% year-to-date as of the close of trading on Monday.

Violin Memory, Inc. develops and supplies memory-based storage systems to bring storage performance in line with high-speed applications, servers, and networks worldwide. Currently, there is 1 analyst who rates Violin Memory a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VMEM - FREE

TheStreet Quant Ratings rates Violin Memory as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself and generally high debt management risk. Get the full Violin Memory Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null